DuBiner, Harvey B <br/><br/>
Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.  [electronic resource] 

 -  BMC ophthalmology  Nov 2014 
 - 151 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2415 
<br/><br/><label>Standard No.: </label>10.1186/1471-2415-14-151  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amides--adverse effects<br/>Antihypertensive Agents--adverse effects<br/>Benzalkonium Compounds--adverse effects<br/>Bimatoprost<br/>Cloprostenol--adverse effects<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Female<br/>Glaucoma, Open-Angle--drug therapy<br/>Humans<br/>Intraocular Pressure--drug effects<br/>Male<br/>Middle Aged<br/>Ocular Hypertension--drug therapy<br/>Ophthalmic Solutions<br/>Preservatives, Pharmaceutical--adverse effects<br/>Prospective Studies<br/>Therapeutic Equivalency<br/>Tonometry, Ocular<br/>Travoprost